Skip to main navigation
Skip to search
Skip to main content
Utrecht University Home
Help & FAQ
Home
Research output
Search by expertise, name or affiliation
Targeting inflammation with autoantigen-specific T cells.
T. Guichelaar
Research output
:
Thesis
›
Doctoral thesis 1 (Research UU / Graduation UU)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Targeting inflammation with autoantigen-specific T cells.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Inflammation
100%
T Cells
100%
Autoantigen
100%
Specific T Cells
100%
Arthritis
66%
Interleukin-10
46%
Cartilage
46%
Proteoglycan
26%
Transgenic Mice
26%
Rheumatoid Arthritis
13%
T Cell Receptor
13%
CD4+ T Cells
13%
Chronic Autoimmune Diseases
13%
Tissue Components
13%
B Cells
13%
Autoimmune Response
13%
Immune System
6%
Tumor Necrosis Factor-α
6%
Multiple Sclerosis
6%
IL-10 Production
6%
Immune Response
6%
Cell-to-cell
6%
Diabetes
6%
Flow Cytometry
6%
T Cell Response
6%
Drug Therapy
6%
Inflammatory Mediators
6%
Joint Inflammation
6%
Chronic Arthritis
6%
Th1 Cells
6%
Arthritogenic
6%
Serious Infection
6%
Arthritis Patients
6%
Interleukin-4 (IL-4)
6%
Regulatory Capacity
6%
Interleukin-1 Receptor Antagonist (IL-1Ra)
6%
Gene Therapy
6%
Interleukin-2
6%
TNF Receptor 1 (TNFR1)
6%
Healthy Individuals
6%
IgG2a
6%
Retroviral Transduction
6%
Interleukin-17 (IL-17)
6%
Recipient Cells
6%
Retrovirus
6%
Immunosuppressive Function
6%
Immunosuppressive Cytokines
6%
Pro-inflammatory Proteins
6%
Mouse Cells
6%
Immunology and Microbiology
Autoantigen
100%
T Cell
100%
Arthritis
65%
Interleukin 10
40%
Cartilage
35%
Immunosuppressive Drug
20%
Transgenic Mouse
20%
Proteoglycan
20%
B Cell
10%
Inflammatory Arthritis
10%
T Cell Receptor
10%
Autoimmunity
10%
T-Helper Cell
10%
Autoimmune Disease
10%
Tumor Necrosis Factor Alpha
10%
Interleukin-1
5%
Immune Response
5%
Mediator
5%
Intravenous Immunoglobulin
5%
Th1 Cell
5%
Immunoglobulin G2a Antibody
5%
Multiple Sclerosis
5%
Interleukin 2
5%
Cytokine
5%
Retrovirus
5%
Transgene
5%
Interleukin 4
5%
Interleukin 17
5%
Immune System
5%
Drug Therapy
5%